Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Propranolol Plus SOX and Toripalimab in Resectable Locally Advanced Gastric or GEJ Adenocarcinoma
NCT07727993Phase 2Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Jun 2027
01
Overview
A Phase 2 trial of propranolol in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT07727993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07727993.